Quoin Pharmaceuticals, Ltd. QNRX

Rank #2407 · Nasdaq · $15.2B market cap

⚠ Going-concern flag — the auditor (CBIZ CPAs P.C.) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

20.3

P/E

-1699.3

P/B

2688.93

ROE

-158.2%

Op. Margin

–%

Debt Ratio

115%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E -1699.3x, P/B 2688.93x. Ranks in the top 80% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -158.2%. Ranks in the top 96% of the universe.

Safety ★★★☆☆

Average

Debt ratio 115%. Ranks in the top 44% of the universe.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2022	–	–	$-0.0B	$-0.0B	–	-132
2023	–	–	$-0.0B	$0.0B	–	1073
2024	–	–	$-0.0B	$0.0B	–	88
2025	–	–	$-0.0B	$0.0B	–	115

← See the full screener